CORONARY

Clinical trials for CORONARY explained in plain language.

Never miss a new study

Get alerted when new CORONARY trials appear

Sign up with your email to follow new studies for CORONARY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug combo aims to halt artery plaque after heart attacks

Disease control Recruiting now

This study tests whether adding evolocumab, a cholesterol-lowering drug, to standard care can slow or stop plaque buildup in heart arteries after a heart attack. About 233 adults aged 40-75 who recently had a heart attack or unstable angina will receive either evolocumab plus sta…

Matched conditions: CORONARY

Phase: PHASE4 • Sponsor: West China Hospital • Aim: Disease control

Last updated Jun 25, 2026 12:08 UTC

CORONARY

Get alerted when new CORONARY trials appear

New drug combo aims to halt artery plaque after heart attacks